These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 25640758)
1. Protection of MPTP-induced neuroinflammation and neurodegeneration by rotigotine-loaded microspheres. Yu X; Yao JY; He J; Tian JW Life Sci; 2015 Mar; 124():136-43. PubMed ID: 25640758 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease. Scheller D; Stichel-Gunkel C; Lübbert H; Porras G; Ravenscroft P; Hill M; Bezard E Neurosci Lett; 2008 Feb; 432(1):30-4. PubMed ID: 18162314 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease. Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742 [TBL] [Abstract][Full Text] [Related]
5. Ropinirole protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism. Park G; Park YJ; Yang HO; Oh MS Pharmacol Biochem Behav; 2013 Mar; 104():163-8. PubMed ID: 23369986 [TBL] [Abstract][Full Text] [Related]
6. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease. Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429 [TBL] [Abstract][Full Text] [Related]
7. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease. Liang Y; Chen C; Xia B; Wu W; Tang J; Chen Q; Tang L; Yang H; Zhang Z; Lu Y; Yang Y; Zhao Y Biomed Res Int; 2019; 2019():4379639. PubMed ID: 30834264 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease. Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes. Isooka N; Miyazaki I; Kikuoka R; Wada K; Nakayama E; Shin K; Yamamoto D; Kitamura Y; Asanuma M Neurochem Int; 2020 Jan; 132():104608. PubMed ID: 31765686 [TBL] [Abstract][Full Text] [Related]
11. Phloretin attenuates behavior deficits and neuroinflammatory response in MPTP induced Parkinson's disease in mice. Zhang G; Yang G; Liu J Life Sci; 2019 Sep; 232():116600. PubMed ID: 31251998 [TBL] [Abstract][Full Text] [Related]
12. Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture. Oster S; Radad K; Scheller D; Hesse M; Balanzew W; Reichmann H; Gille G Eur J Pharmacol; 2014 Feb; 724():31-42. PubMed ID: 24365490 [TBL] [Abstract][Full Text] [Related]
13. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents. Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotection in Parkinson models varies with toxin administration protocol. Anderson DW; Bradbury KA; Schneider JS Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378 [TBL] [Abstract][Full Text] [Related]
15. The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice. Stuckenholz V; Bacher M; Balzer-Geldsetzer M; Alvarez-Fischer D; Oertel WH; Dodel RC; Noelker C J Parkinsons Dis; 2013; 3(2):161-72. PubMed ID: 23938346 [TBL] [Abstract][Full Text] [Related]
16. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease. Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060 [TBL] [Abstract][Full Text] [Related]
17. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730 [TBL] [Abstract][Full Text] [Related]
18. Rotigotine-loaded microspheres exerts the antinociceptive effect via central dopaminergic system. Li T; Wang L; Zhang L; Li B; Wang D; Zhang L; Wang T; Fu F Eur J Pharmacol; 2021 Nov; 910():174443. PubMed ID: 34464604 [TBL] [Abstract][Full Text] [Related]
19. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism. Anderson DW; Bradbury KA; Schneider JS Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732 [TBL] [Abstract][Full Text] [Related]
20. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. Sriram K; Matheson JM; Benkovic SA; Miller DB; Luster MI; O'Callaghan JP FASEB J; 2006 Apr; 20(6):670-82. PubMed ID: 16581975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]